search
Back to results

Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot)

Primary Purpose

Colorectal Cancer

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
Lifestyle intervention
Sponsored by
Centre Leon Berard
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Colorectal Cancer focused on measuring Colorectal cancer, Higher risk, Lifestyle intervention

Eligibility Criteria

35 Years - 74 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • 35-74 years of age
  • At increased risk for developing colorectal cancer (CRC), defined here as having a positive faecal immunochemical test (FIT), or family history or symptoms for CRC and identified adenomas but CRC negative during the colonoscopy
  • Volunteer and available to get involved in the project throughout the duration of the study,
  • Be able to provide informed consent
  • Having health insurance (Affiliated to the French social security)
  • Score on the adherence to the WCRF recommendations lower or equal to 6 out of 9 (the WCRF score will be assessed based on a short lifestyle questionnaire, annex 1)
  • Able to read, write and understand French language

Exclusion Criteria:

  • On a strict diet such as meal replacements, diets for co-morbidities such as diabetes
  • Lacking mobility due to physical constraints (e.g. handicap that is not compatible with physical activities, uncontrolled cardiovascular diseases/hypertension)
  • Planned extensive intestinal surgery such as colectomy or surgical resection of the colon
  • Chronic gastrointestinal illness (IBD, IBS, celiac disease)
  • Use of any systemic antibiotics, antifungals, antivirals, or antiparasitics in the past 3 months
  • Use of probiotic medications in the past 3 months
  • History or existence of a primary cancer (apart from an in-situ cancer whatever the location and / or of a cutaneous basal cell cancer and / or of a CRC in complete remission for more than 5 years)
  • In a state of severe malnutrition, either:

    ≥10% weight loss in 1 month or ≥ 15% in 6 months

  • Cannot be followed for medical, social, family, geographic or psychological reasons, throughout the duration of the study
  • Deprived of liberty by court or administrative decision
  • Pregnant (for women)
  • Concomitant participation in another study on lifestyle
  • Optimal lifestyle habits (WCRF score >6) will also be excluded from the pilot study as this participants are not part of target population that could benefit significantly from lifestyle advice (short screener will be completed by patients while in waiting room for pre-colonoscopy visit).

Patients who will be positive for CRC (histological confirmation after colonoscopy) will end prematurely the study.

Sites / Locations

  • Centre Léon BérardRecruiting
  • Hôpital Edouard Herriot (HCL)Recruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Lifestyle intervention

Arm Description

Lifestyle intervention among participants of the French colorectal cancer screening program

Outcomes

Primary Outcome Measures

Changes in adherence to the lifestyle recommendations between baseline and the 4 week follow-up
Adherence to the lifestyle recommendations will be measured by the WCRF questionnaire (Diet and Physical Activity)

Secondary Outcome Measures

Full Information

First Posted
March 1, 2022
Last Updated
August 29, 2023
Sponsor
Centre Leon Berard
search

1. Study Identification

Unique Protocol Identification Number
NCT05273931
Brief Title
Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot)
Official Title
Evaluation of a Lifestyle Intervention Among Participants of the French Colorectal Cancer Screening Program (LIFE-SCREEN Pilot)
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Recruiting
Study Start Date
March 16, 2022 (Actual)
Primary Completion Date
December 2023 (Anticipated)
Study Completion Date
December 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Leon Berard

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study aims to evaluate the impact of promoting advice on the latest evidence-based diet and lifestyle recommendations for cancer prevention at colorectal cancer (CRC) screening among individuals who may be at higher risk for developing CRC. The overall aim of this LIFE-SCREEN pilot study is to test the trial methods and procedures to be used in the LIFE-SCREEN cluster randomized RCT, in order to discover obstacles and problems prior to the main RCT so that corrective actions can be taken to improve the research process. The patients (n=40) will be recruited at the Centre Léon Bérard and at the Hôpital Edouard Herriot at the time of CRC screening. After inclusion, the intervention material (documents explaining the strategies to achieve and maintain recommended behaviours as part of a healthier lifestyle) may be given to the patient during the pre-colonoscopy consultation and/or at the post-colonoscopy visit. Weight, height and blood pressure will be measured during the pre-colonoscopy consultation. Patients will be invited to complete a baseline questionnaire to collect information on their lifestyle, state of health and socio-demographic status. Approximately four to six weeks after, patients will also be asked to complete an evaluation questionnaire asking for their opinion on this material and the procedures. Focus groups with available and willing participants and hospital staff will be organized at the end of the pilot phase recruitment, to gather additional information on the intervention procedures. In addition, all hospital staff will be asked to complete an assessment questionnaire. Biological samples will then also be collected to test the objective baseline measure of nutritional changes used in the RCT. In order to assess the feasibility and the acceptability of urine, faecal and blood sample collection in this population, the first ten participants recruited (n=10) will be given the option to refuse one or more of the biological sample collections (phase I). Participants will also be asked to complete a questionnaire to provide information on their opinion and willingness to donate biological samples. This assessment questionnaire will allow us to refine the strategies for the other 30 participants (phase II). In this phase II, biological samples will be compulsory (phase IIa) or optional (phase IIb) for all 30 participants.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Colorectal Cancer
Keywords
Colorectal cancer, Higher risk, Lifestyle intervention

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Lifestyle intervention
Arm Type
Experimental
Arm Description
Lifestyle intervention among participants of the French colorectal cancer screening program
Intervention Type
Other
Intervention Name(s)
Lifestyle intervention
Intervention Description
Documents explaining the strategies to achieve and maintain recommended behaviours as part of a healthier lifestyle
Primary Outcome Measure Information:
Title
Changes in adherence to the lifestyle recommendations between baseline and the 4 week follow-up
Description
Adherence to the lifestyle recommendations will be measured by the WCRF questionnaire (Diet and Physical Activity)
Time Frame
Change between Baseline and Week 4

10. Eligibility

Sex
All
Minimum Age & Unit of Time
35 Years
Maximum Age & Unit of Time
74 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: 35-74 years of age At increased risk for developing colorectal cancer (CRC), defined here as having a positive faecal immunochemical test (FIT), or family history or symptoms for CRC and identified adenomas but CRC negative during the colonoscopy Volunteer and available to get involved in the project throughout the duration of the study, Be able to provide informed consent Having health insurance (Affiliated to the French social security) Score on the adherence to the WCRF recommendations lower or equal to 6 out of 9 (the WCRF score will be assessed based on a short lifestyle questionnaire, annex 1) Able to read, write and understand French language Exclusion Criteria: On a strict diet such as meal replacements, diets for co-morbidities such as diabetes Lacking mobility due to physical constraints (e.g. handicap that is not compatible with physical activities, uncontrolled cardiovascular diseases/hypertension) Planned extensive intestinal surgery such as colectomy or surgical resection of the colon Chronic gastrointestinal illness (IBD, IBS, celiac disease) Use of any systemic antibiotics, antifungals, antivirals, or antiparasitics in the past 3 months Use of probiotic medications in the past 3 months History or existence of a primary cancer (apart from an in-situ cancer whatever the location and / or of a cutaneous basal cell cancer and / or of a CRC in complete remission for more than 5 years) In a state of severe malnutrition, either: ≥10% weight loss in 1 month or ≥ 15% in 6 months Cannot be followed for medical, social, family, geographic or psychological reasons, throughout the duration of the study Deprived of liberty by court or administrative decision Pregnant (for women) Concomitant participation in another study on lifestyle Optimal lifestyle habits (WCRF score >6) will also be excluded from the pilot study as this participants are not part of target population that could benefit significantly from lifestyle advice (short screener will be completed by patients while in waiting room for pre-colonoscopy visit). Patients who will be positive for CRC (histological confirmation after colonoscopy) will end prematurely the study.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Aurélia MAIRE, MSc
Phone
0469856362
Email
aurelia.maire@lyon.unicancer.fr
First Name & Middle Initial & Last Name or Official Title & Degree
Olivia PEROL, MSc
Phone
0478782897
Email
olivia.perol@lyon.unicancer.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anne CATTEY-JAVOUHEY, MD, PhD
Organizational Affiliation
Centre Leon Berard
Official's Role
Principal Investigator
Facility Information:
Facility Name
Centre Léon Bérard
City
Lyon
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aurélia MAIRE, MSc
Phone
0469856362
Email
aurelia.maire@lyon.unicancer.fr
First Name & Middle Initial & Last Name & Degree
Anne CATTEY-JAVOUHEY, MD,PhD
Facility Name
Hôpital Edouard Herriot (HCL)
City
Lyon
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Aurélia MAIRE, MSc
Phone
0469856362
Email
aurelia.maire@lyon.unicancer.fr
First Name & Middle Initial & Last Name & Degree
Jean-Christophe SAURIN, MD,PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Lifestyle Intervention After Colonoscopy (LIFE-SCREEN Pilot)

We'll reach out to this number within 24 hrs